Editorial Policy

The editorial policy of the journal “Therapeutics / named after Prof. Berezhnytskyi M.M.” is based on international ethical and editorial principles, in particular the recommendations of the World Association of Medical Editors (WAME) and the principles of the San Francisco Declaration on Research Assessment (DORA).

The journal adheres to the principles of transparency, editorial independence, academic integrity, and responsible research assessment. All editorial decisions are made solely on the basis of scientific quality, methodological soundness, originality, and clinical relevance of the submitted materials, without influence from institutional, financial, or bibliometric factors.

Copyright and Licensing:

Authors retain copyright  and grant the journal the right of first publication.

All articles in the journal are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which states that:

You are free to:

1. Copy and redistribute the material in any form or format for any purpose, including commercial ones.
2. Modify, remix, transform, and build upon the material for any purpose, including commercial ones.
3. The licensor cannot revoke these permissions as long as you comply with the terms of the license.

Under the following terms:

1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Authors have the right to enter into separate contractual arrangements regarding the non-exclusive distribution of a version of the work as published here (e.g., placement in the institute's archive, publication in a book), with reference to the initial original publication in this journal.

Peer Review:

All materials submitted to the editorial office of the journal "Therapeutics / Named after Prof. M.M. Berezhnytskyi" must undergo external double-blind peer review, the purpose of which is to provide authors with constructive criticism to improve the quality of the manuscript and ensure high standards of published materials. The peer review process includes:

1.Initial assessment by the editors:

The editor-in-chief checks the manuscript for accordance with the scope of the journal, assesses the relevance of the topic, the presence of scientific novelty and accordance with the requirements for its design. If the article significantly does not meet the requirements of the journal and requires considerable correction, it may be rejected without review (desk reject).

2.Selection of reviewers:

The Editor-in-Chief appoints at least two external independent reviewers who are experts in the relevant field, as evidenced by their publication history. The peer review is double-blind, meaning that the reviewer is not given the personal information of the author(s), and similarly, the author(s) are not given the identity or personal information of the reviewer.

3.The actual peer-review:

The review procedure usually lasts for one month. The manuscript is evaluated on the basis of relevance and novelty, the presence of theoretical and applied significance, the correspondence of the applied approaches and statistical methods to the research task, the sufficient validity of the results obtained, and the authors' compliance with the rules of scientific ethics. If any evidence of manipulation or falsification of data is discovered, the manuscript will be rejected. Reviewers evaluate the article and provide their conclusions in writing, which correspond to the overall assessment of the work, comments and recommendations:

• accept for publication,
• sent to the author or authors for revision,
• reject the article.

In cases of disagreement between the reviewers' recommendations, additional external reviewers are invited.

4.Editorial decision:

The journal Editorial Board reads the reviews and makes a final decision: to accept, request minor or major revisions, or reject. This decision is sent to the author(s) along with the reviewers' conclusions, comments, and remarks of the editors.

5.Re-review (if necessary):

After the authors have revised the manuscript, in case of significant corrections and changes, the editor may re-send the article for re-review by the same reviewers. They re-evaluate the work, taking into account the previous comments and changes made, and provide a reasoned written decision on acceptance or rejection of the article for publication.

Editors and editorial staff are not authorized to disclose information about submitted works to anyone except the respective authors, reviewers, other editorial consultants, and, if necessary, the publisher.

The editor and editorial staff do not have the right to use in any way unpublished materials contained in the submitted manuscript.

Publication fee:

Publishing in the journal "Terapevtyka" is completely free of charge for authors. The journal does not charge any publication fees, editorial fees, or other charges related to the process of submitting, reviewing, editing, or publishing scientific articles. This policy is aimed at supporting open access to scientific knowledge, encouraging researchers to share the results of their work, and promoting the free development of medical science without financial barriers.

Complaints and Appeals:

The journal “Therapeutics / named after Prof. Bereznytskyi M.M.” adheres to the principles of transparency, impartiality, and accountability in accordance with COPE guidelines. All complaints and appeals are handled fairly, regardless of the authors’ or reviewers’ status.

Authors are encouraged to first resolve any issues arising during the peer-review process through scholarly discussion with reviewers via the editorial system. If the issue cannot be resolved at this stage, the author has the right to submit a formal appeal.

A formal complaint or appeal must be submitted in writing to the Editor-in-Chief and should include the manuscript identifier, a clear description of the issue, and, where applicable, supporting evidence. The complaint is reviewed by the Editor-in-Chief or a designated editorial board member who was not involved in the original decision. If necessary, an independent editorial board member or an external expert may be consulted.

Possible outcomes of the review include:

• confirmation of the original editorial decision;
• revision of the decision;
• re-review of the manuscript;
• initiation of an investigation in accordance with COPE guidelines in cases of potential ethical misconduct.

In cases of serious breaches of academic integrity, the editorial office reserves the right to contact the authors’ affiliated institutions.

The journal documents all complaints, the review process, and the final decisions to ensure transparency and enable further ethical audit if required.

Contacts for Complaints and Appeals:

Editorial Office:
terapevtyka.journal@gmail.com

Editor-in-Chief of the journal “Therapeutics / named after Prof. Bereznytskyi M.M.”
Skripnyk Nadiia Vasylivna, +38 (067) 342 39 67
nskrypnyk@ifnmu.edu.ua
skrypnyknadiya@gmail.com

Procedure for Retraction of Published Articles:

The purpose of retraction is to inform the scientific community about the unreliability or inaccuracy of certain publications, not to punish the authors.

Retraction of a published article is carried out in cases where violations of academic integrity or significant errors that affect the reliability of published results are identified.
The retraction procedure is conducted in accordance with the ethical principles outlined in the recommendations of the Committee on Publication Ethics (COPE).

An article may be retracted in the following cases:

• detection of plagiarism, falsification, or fabrication of data;
• submission of identical materials to multiple journals (duplicate publication);
• discovery of serious methodological or analytical errors that distort the research results;
• violation of ethical standards of research;
• improper authorship (exclusion or inclusion of authors without their consent);
• decisions by judicial or institutional bodies confirming data unreliability.

A retraction may be initiated by:

• the author (or authors) of the publication;
• the editorial board of the journal;
• readers, reviewers, or institutions that have identified violations.

The editorial team conducts a preliminary investigation, during which explanations are obtained from the authors and, if necessary, from third parties. After the investigation is completed, the final decision is made by the Editor-in-Chief in consultation with the editorial board.

In the event of a retraction:

• The title of the publication сhanges to “Retracted: [Article Title]”;
• The full text of the article remains available in the electronic version, marked with a “RETRACTED / ВІДКЛИКАНО” watermark on each page;
• An official retraction notice is published at the beginning of the PDF file of the retracted article, which includes:
  
  • the title and authors of the retracted article;
  • the reason for retraction;
  • a reference to the original publication;
  • the date of the decision;
  • the signature of the Editor-in-Chief.

The retraction notice is open and publicly available in the journal’s database. Retracted articles are not removed from the journal archives; they remain in the database with an appropriate retraction label. The Editorial Board notifies the relevant databases and indexing services about the retraction in order to update the publication’s status in their systems.

Archiving, depositing and preservation:

Authors have the right to deposit submitted materials in online platforms, including institutional repositories or personal websites, both before and during the peer-review process. This practice promotes open scientific discussion, increases the visibility of research, and may contribute to higher citation impact.

Authors guarantee that the submitted materials have not been previously transferred to third parties under formal agreements for exclusive reproduction or other restricted use. In case the work has been previously published or made available in other sources, the authors are obliged to inform the editorial office at the time of submission.

The journal supports an open access policy, as well as the archiving and long-term preservation of scholarly content, ensuring its stable and continuous availability over time. Published materials may be stored in the journal’s electronic archive and/or in designated institutional or national repositories to guarantee long-term accessibility, preserve the integrity of the scholarly record, and support open science principles.

• • • • • • • • • • • • • Updated 14th of April 2026